Navigation Links
RedPrairie: Will they stay, or will they go?

Waukesha, Wis. - Former Kimberly-Clark CEO Darwin Smith may or may not have brought down a governor, but he certainly sparked a debate.

It was 1983, and Wisconsin had just elected liberal Democrat Tony Earl as governor. Earl attempted to address a budget deficit with an income tax increase, and Smith issued a dire warning about the impact......

Full article >>> br>
State Secretary of Commerce Mary Burke has placed a call to Jazwiec to discuss his concerns, but he was traveling this week and no formal meeting has been set. "We'll contact him to see what he says, and see if there's a way that we can be helpful," said Tony Hozeny, communications officer for the Department of Commerce. "Anytime someone says what he said, of course we're concerned."
......

Full article >>> governor during 14 years of economic expansion. The current governor, Jim Doyle, pledged to be a different kind of Democrat on economic matters, and even his harshest critics would have to concede that he largely has kept his word, signing a series of business and investment friendly bills passed by a Republican-controlled legislature. One of those new laws repealed shareholder liability.

Full article >>> lent, he would point out the quality of the state's university system and workforce, and reinforce that as much as possible. "If the talent is here, they [RedPrairie] will stay," he said. "It's going to come down to people."

RedPrairie may have another motivation, Rice conceded, and that is a desire to move closer to its parent company. RedPrairie was acquired in 2005 by the investment fi......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/21/06


Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, ... strange place for a head lice treatment salon to set ... a Tuscan restaurant and a French bistro on E Madison ... "We aren,t just any old lice clinic, we pride ourselves ... comfortable, and release some of the stigma associated with lice. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
(Date:2/23/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... the international society for optics and photonics , have been named Fellows of ... individual’s significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):